Summary of the workshop "The Pre-Clinical Safety Evaluation of Biotechnology : Derived Pharmaceuticals"(WORKSHOP 1 : THE WAY TOXICITY EVALUATIONS OF BIO-PHARMACEUTICAL PRODUCTS SHOULD BE CONDUCTED (TOXICOLOGICAL QUESTIONS & ANSWERS-ISSUE 2002).ICH-S6)